EarliPoint Health receives expanded FDA clearance for autism assessment in children up to age 8.

Read Release →

From Social Attention to Generative Language: Rethinking Early Autism Intervention

In this episode of the EarliPoint Exchange, Dr. Cheryl Tierney and Kirsten Yurich, BCBA, are joined by Dr. Ami Klin, a leader in developmental neuroscience and autism research, and Dr. Caio Miguel, Professor of Psychology and Director of the Verbal Behavior Research Lab at California State University, Sacramento.

This conversation bridges the gap between early social attention differences and the development of generative language in children with autism. Dr. Klin will discuss foundational work in early social engagement and its role in autism identification, while Dr. Miguel will explore how behavior analytic approaches can assess and teach generative language skills using naturalistic, developmentally informed strategies.

The discussion will highlight how advances in neuroscience, behavioral science, and assessment are converging to inform earlier, more precise, and more effective intervention models.

The webinar will be held on May 26th, from 12PM-1PM, and includes 1 BACB® GEN CEU. Attendance is included free with a BehaviorLive subscription, and registrants will also have access to the recorded session on-demand for CEUs.

Learning Objectives

  • Explain the relationship between early social attention and the development of communication and language in autism.
  • Describe behavior analytic strategies for assessing and teaching generative language skills, including naturalistic approaches.
  • Evaluate how integrating developmental science and applied behavior analysis can improve early intervention outcomes.

Register now to reserve your spot and explore how groundbreaking research in eye-tracking is advancing the future of autism diagnosis and assessment.

Pete Polgar

VP of Marketing

Pete Polgar is the Vice President of Marketing at Earlipoint. He leads the company’s marketing strategy, focusing on brand positioning, demand generation, and digital growth. With a background in performance marketing and content strategy, Pete works on aligning marketing initiatives with business development to drive measurable results and expand Earlipoint’s market presence.

Latest News

See how EarliPoint fits seamlessly into your clinical workflow.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder